- March 15, 2022
- Newsletter
- 617-430-5616
Menu
Menu
Menu
Menu
Menu
Menu
Brand Name :
Nesina,Incresync,kazano,oseni
Synonyms :
Alogliptin, Alogliptin
Class :
Anti-diabetics, Dipeptidyl Peptidase-IV Inhibitors
Dosage Forms & Strengths
Tablet
6.25mg
12.5mg
25mg
25
mg
Orally
every day
Tablet
may increase the hypoglycemic effect
may increase the hypoglycemic effect
may increase the hypoglycemic effect
may increase the hypoglycemic effect
may increase the hypoglycemic effect
Dipeptidyl Peptidase-IV Inhibitors: they may increase the hypoglycemic effect of insulins
Dipeptidyl Peptidase-IV Inhibitors: they may increase the hypoglycemic effect of insulins
Dipeptidyl Peptidase-IV Inhibitors: they may increase the hypoglycemic effect of insulins
Dipeptidyl Peptidase-IV Inhibitors: they may increase the hypoglycemic effect of insulins
Dipeptidyl Peptidase-IV Inhibitors: they may increase the hypoglycemic effect of insulins
Dipeptidyl Peptidase-IV Inhibitors: they may increase the hypoglycemic effect of sulfonylureas
Dipeptidyl Peptidase-IV Inhibitors: they may increase the hypoglycemic effect of sulfonylureas
Dipeptidyl Peptidase-IV Inhibitors: they may increase the hypoglycemic effect of sulfonylureas
Dipeptidyl Peptidase-IV Inhibitors: they may increase the hypoglycemic effect of sulfonylureas
Dipeptidyl Peptidase-IV Inhibitors: they may increase the hypoglycemic effect of sulfonylureas
may increase the hypoglycemic effect of Sulfonylureas
may diminish the hypoglycemic effect
may increase the hypoglycemic effect of Antidiabetic Agents
Dipeptidyl Peptidase-IV Inhibitors: they may increase the toxic effect of angiotensin-converting enzyme inhibitors
Dipeptidyl Peptidase-IV Inhibitors: they may increase the toxic effect of angiotensin-converting enzyme inhibitors
Dipeptidyl Peptidase-IV Inhibitors: they may increase the toxic effect of angiotensin-converting enzyme inhibitors
Dipeptidyl Peptidase-IV Inhibitors: they may increase the toxic effect of angiotensin-converting enzyme inhibitors
Dipeptidyl Peptidase-IV Inhibitors: they may increase the toxic effect of angiotensin-converting enzyme inhibitors
When medrysone is used in conjunction with alogliptin, the risk or seriousness of hyperglycemia can rise
When used with levobetaxolol, alogliptin's therapeutic effectiveness may be enhanced
may have an increasingly adverse effect when combined with angiotensin-converting enzyme inhibitors
may have an increasingly adverse effect when combined with angiotensin-converting enzyme inhibitors
may have an increasingly adverse effect when combined with angiotensin-converting enzyme inhibitors
may have an increasingly adverse effect when combined with angiotensin-converting enzyme inhibitors
when both drugs are combined, there may be a decreased therapeutic efficacy of alogliptin
may increase the hypoglycemic effect
choline magnesium trisalicylate
may increase the hypoglycemic effect
may increase the hypoglycemic effect
may increase the hypoglycemic effect
may increase the hypoglycemic effect
may increase the hypoglycemic effect
may increase the hypoglycemic effect
dipeptidyl peptidase-IV inhibitors increase the effect of hypoglycemia of sulfonylureas
dipeptidyl peptidase-IV inhibitors increase the effect of hypoglycemia of sulfonylureas
dipeptidyl peptidase-IV inhibitors increase the effect of hypoglycemia of sulfonylureas
dipeptidyl peptidase-IV inhibitors increase the effect of hypoglycemia of sulfonylureas
dipeptidyl peptidase-IV inhibitors increase the effect of hypoglycemia of sulfonylureas
dipeptidyl peptidase-IV inhibitors increase the effect of hypoglycemia of insulins
dipeptidyl peptidase-IV inhibitors increase the effect of hypoglycemia of insulins
dipeptidyl peptidase-IV inhibitors increase the effect of hypoglycemia of insulins
dipeptidyl peptidase-IV inhibitors increase the effect of hypoglycemia of insulins
dipeptidyl peptidase-IV inhibitors increase the effect of hypoglycemia of insulins
Frequency defined:
>10%
Hypoglycemia
1-10%
Headache
Nasopharyngitis
Upper respiratory tract infections
<1%
Pancreatitis
Hypersensitivity
Post-marketing reports
Ileus
Diarrhea
Rhabdomyolysis
Hepatic failure
Stevens-Johnson syndrome
Arthralgia
Tubulointerstitial nephritis
Nausea
Constipation
Angioedema
Urticaria
Pregnancy consideration: B
Lactation: Excretion of the drug in human breast milk is unknown
Pregnancy category:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Patient information leaflet
Generic Name: alogliptin
Pronounced: AL-oh-GLIP-tin
Why do we use alogliptin?
It is used to treat hyperglycemia (High sugar levels) in patients suffering from type 2 diabetes mellitus
ADVERTISEMENT
Founded in 2014, medtigo is committed to providing high-quality, friendly physicians, transparent pricing, and a focus on building relationships and a lifestyle brand for medical professionals nationwide.
USA – BOSTON
60 Roberts Drive, Suite 313
North Adams, MA 01247
INDIA – PUNE
7, Shree Krishna, 2nd Floor, Opp Kiosk Koffee, Shirole Lane, Off FC Road, Pune 411004, Maharashtra
Founded in 2014, medtigo is committed to providing high-quality, friendly physicians, transparent pricing, and a focus on building relationships and a lifestyle brand for medical professionals nationwide.
MASSACHUSETTS – USA
60 Roberts Drive, Suite 313,
North Adams, MA 01247
MAHARASHTRA – INDIA
7, Shree Krishna, 2nd Floor,
Opp Kiosk Koffee,
Shirole Lane, Off FC Road,
Pune 411004, Maharashtra
